Tradestie Institutional Equity Comparison Engine
WEST vs BHST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
WEST Overall Edge
WEST Captures Institutional Edge (3โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Westrock Coffee Company Common Stock (WEST) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, WEST trades at N/M Forward P/E with -1.2% operating margin (-15.4% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, WEST sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
WEST N/M vs BHST N/M Fwd P/E
Growth & Margin Winner
WEST
Op Margin -1.2% vs -18.0% ยท YoY -15.4% vs +3.8%
Momentum & Technical Winner
WEST
1Y +73.1% vs -79.4% ยท 52W Pos 49% vs 6%
Options & Structure Winner
WEST
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
WEST
NASDAQ
Westrock Coffee Company Common Stock
Beverages
$7.22
-1.37% 1D
Market Cap
$732.5M
1M Return
-25.49%
1Y Return
+73.14%
Forward P/E
N/M
Unified AI Score
44.7 / 100
HOLD
Tech 25.0
Fund 46.0
Flow 58.0
Mom 55.0
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
WEST +73.14%
BHST -79.4%
Spread: +152.54 pp (WEST Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | WEST Revenue | BHST Revenue | WEST Op. Margin | BHST Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | $550M | N/A | -21.9% | N/A | WEST |
| FY2021 | $700M | N/A | 1.1% | N/A | WEST |
| FY2022 | $870M | N/A | 1.0% | N/A | WEST |
| FY2023 | $860M | $10M | -2.4% | -78.6% | WEST |
| FY2024 | $850M | $30M | -5.8% | -27.7% | WEST |
| FY2025 | $1.19B | $30M | -3.8% | -16.2% | WEST |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | WEST | BHST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $732.5M | $29.9M | Larger Scale | WEST |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -15.4% | +3.8% | Higher Growth | BHST |
| Operating Margin (TTM) Profitability | -1.2% | -18.0% | Higher Margin | WEST |
| Net Profit Margin Profitability | -4.4% | -31.2% | Higher Margin | WEST |
| Return on Equity (ROE) Capital Efficiency | -20.9% | -142.5% | Higher ROE | WEST |
| 52-Week Range Position Momentum | 49% ($4โ$11) | 6% ($1โ$7) | Stronger Trend | WEST |
| Beta / 30D Volatility Risk Regime | 0.56ฮฒ ยท 69% Vol | 0.25ฮฒ ยท 86% Vol | Lower Realized Risk | WEST |
| Unified Institutional Score Composite Signal | 44.7 / 100 (HOLD) | 58.2 / 100 (HOLD) | Higher Composite | BHST |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full WEST vs BHST Buy Guide
WEST
CONSOLIDATION
112d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither WEST nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.